Financials
- Market Capitalization 37.93 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry 전문의약품 및 제네릭 의약품 제조업체
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-0.17
주가매출액비율
-7.22
주당 배당금
49.5
배당수익률 %
—
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 4254 | INCR Intercure Ltd. - ordinary shares | 1.00 USD | +5.26% | +5.26% | +6.38% | -34.21% | 54.68 M USD | ||
| 4304 | SCYX SCYNEXIS, Inc. - Common Stock | 4.93 USD | +10.04% | +7.64% | +20.24% | +557.33% | 48.96 M USD | ||
| 4435 | ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 0.73 USD | +2.82% | -5.19% | -8.75% | -70.08% | 34.60 M USD | ||
| 4539 | CPHI China Pharma Holdings, Inc. Common Stock | 0.61 USD | +1.67% | -10.29% | -19.74% | -7.73% | 24.72 M USD |